GovChime
Notice ID: 31e3dea0a4874442b2ad847abac50974Solicitation

Battlefield Pain Management – Analgesic

Responses closed . Full description on SAM.gov.

Overview

Response deadline
12:00 PM EDT
Posted
July 23, 2026
Notice type
Solicitation
Set-aside
No Set aside used
NAICS
541714: Research and Development in Biotechnology (except Nanobiotechnology)
Agency
Department of WarDEFENSE HEALTH AGENCY (DHA)

Notice details

Office
DEFENSE HEALTH AGENCY
Place of performance
Frederick, Maryland, 21702
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
HT942726RE009
Notice ID
31e3dea0a4874442b2ad847abac50974

Description

This Request for Prototype Proposal (RPP) is being issued under the authority of prototype Other Transaction Authority (pOTA) 10 U.S.C. 4022 by the Defense Health Agency Contracting Activity (DHACA), in support of the Defense Health Agency, Portfolio Acquisition Executive Medical Products (PAE MP), Warfighter Protection and Acute Care Project Management Office (WPAC PMO) located in Frederick, Maryland, at Fort Detrick. The requirement is for Analgesic Product for Battlefield Use. Please see the attached RPP and attachments for additional information.

Amendment 0001
The purpose of Amendment 0001 is to:

1. Amend the Request for Prototype Proposal (RPP) as follows:
     - Extend the proposal due date from 30 July 2026 to 14 August 2026 (RPP Amendment 0001, page 1 and page 17). No additional questions/phone calls regarding the RPP will be accepted.
     - Update the word “drug” to “product” to align with the language (RPP Amendment 0001, page 2, section 1.1, third paragraph)
     - Clarify language regarding the Spend Plan (RPP Amendment 0001, page 13, section 3.5 Volume III: Administrative and Cost Volume, Attachment E – Cost Sheet Template with priced milestones, first paragraph).
     - Add additional Vendor requirements (RPP Amendment 0001, page 15, section 3.5 Volume III: Administrative and Cost Volume, Other Administrative Requirements).

2. Amend the RPP, Attachment A – Statement of Objectives (SOO) as follows:

     - Update the Revised Date (page 1).
     - Update language throughout to clarify the Government’s intent regarding drug versus product.
          - page 1, section 1. Purpose/Objective, second and third paragraphs
          - page 2, section 4 Objectives, second, third and fifth paragraphs
          - page 3, section 4 Objectives, first paragraph
          - page 5, Desirable prototype characteristics and performance, first paragraph

     - Revise the following Desirable prototype characteristics and performance: (2), (6), (9), and (13) (page 5 and page 6).

     - Revise the following Deliverables: Deliverable 3 and Deliverable 12 (page 7 and page 9, respectively).

3. Answer questions received from potential performers (see RPP Amendment 0001, Attachment 1).

There are no other changes.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (11)

  • B08-HT942726RE009-RPP-Amend0001-Attach1-Questions-Answers-from-Potential-Performers.pdf

    81 KBAdded in Solicitation version 3Posted
    Download
  • B08-HT942726RE009-RPP-Amend0001-AttachA-SOO-rev1-20260723.pdf

    266 KBAdded in Solicitation version 3Posted
    Download
  • B08-HT942726RE009-RPP-Amend0001.pdf

    261 KBAdded in Solicitation version 3Posted
    Download
  • B08-HT942726RE009-RPP-AttachG-DI-TCSP-82040.pdf

    378 KBAdded in Solicitation version 2Posted
    Download
  • B08-HT942726RE009-RPP-AttachF-CDRL-A001-A003-20260608-Final-Redacted.pdf

    467 KBAdded in Solicitation version 2Posted
    Download
  • B08-HT942726RE009-RPP-AttachE-Cost-Summary-Sheet.xlsx

    24 KBAdded in Solicitation version 2Posted
    Download
  • B08-HT942726RE009-RPP-AttachD-Prohibition-Contracting-Malign-Foreign-Talent-Programs.docx

    26 KBAdded in Solicitation version 2Posted
    Download
  • B08-HT942726RE009-RPP-AttachC-Warranties-and-Representations.docx

    38 KBAdded in Solicitation version 2Posted
    Download
  • B08-HT942726RE009-RPP-AttachB-Draft-OTA-Agreement-for-Prototype-20260608-Final.docx

    156 KBAdded in Solicitation version 2Posted
    Download
  • B08-HT942726RE009-RPP-AttachA-SOO-20260608-Final.pdf

    264 KBAdded in Solicitation version 3Posted
    Download
  • B08-HT942726RE009-RPP-20260629-Final.pdf

    259 KBAdded in Solicitation version 2Posted
    Download

Lifecycle

  1. 5
    Version 5PresolicitationArchived

    Battlefield Pain Management – Analgesic

    Notice 9ab96865df474166bcbb255fc1bc718a on SAM.gov

  2. 2
    Version 2Solicitation

    Type changed from Presolicitation to Solicitation

    Battlefield Pain Management – Analgesic

    Notice 845958a9222c45f18d6044bdb22897cc on SAM.gov

  3. 3
    Version 3SolicitationCurrent

    Battlefield Pain Management – Analgesic

    Notice 31e3dea0a4874442b2ad847abac50974 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
-Special Notice11/02/2026
Redacted Justification and Approval (J&A) for Other than Full and Open Competition to award a new firm fixed price Research and Development contract to obtain the Product Lifecycle Management (PLM) activities necessary to sustain the commercial viability of a Single Donor, Type Specific, universal Freeze-Dried Plasma (FDP) product made by Vascular Solutions LLC (a subsidiary of Teleflex Incorporated).
-AwardedOpen
Amendment 0001 to this notice is to push out the anticipated posting of the solicitation to late November 2026. This is a pre-solicitation notice to synopsize the intention of the Defense Health Agency Contracting Activity (DHACA) to issue a Request for Proposal (RFP) for an on-ramp to the OMNIBUS IV Multiple Award, Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle covering military medical research and development services. A historical pre-solicitation notice was posted under Notice ID# HT942626RE002, although there were various delays with getting a solicitation out in Fiscal Year 2026. This notice is taking over where Notice ID# HT942626RE002 left off. No further delays are anticipated at this time for this on-ramp. The eventual RFP will be set-aside for small businesses certified under the Small Business Administration 8(a) Program. The Government anticipates making multiple new awards under this on-ramp, and all new awards will align with the existing unrestricted contract vehicle. This notice is not a request for proposals and does not commit the Government to any contractual agreement. The OMNIBUS IV contract vehicle was awarded under full and open competition with a base ordering period of 20 June 2022 through 19 June 2027 and an Option Ordering Period of 20 June 2027 - 19 June 2032. Task orders may be competed under fair opportunity (providing all Contract Holders within a Market Segment the opportunity to submit a proposal) or an exception to fair opportunity (such as set-asides for small businesses or applicable small business socioeconomic categories). The cumulative ceiling of this unrestricted IDIQ contract vehicle is $10 billion. To date, the accumulated awarded task order value (including future unexercised option periods) is over $690 million across 61 task orders. Task Orders have been issued by a growing number of end users including DHACA, the U.S. Army Medical Research Acquisition Activity (now integrated into DHACA), the Naval Supply Systems Command, and the Uniformed Services University of the Health Sciences. When excluding the task orders simply providing a minimum guarantee to the existing Contract Holders, 61 task orders have been issued off this contract vehicle with 8 task orders being set aside for the 8(a) Program and 15 task orders being awarded to an 8(a) Participant (based on the most recent representations at the contract level). 42 task orders have been awarded so far to small businesses under this contract vehicle. Of the 61 task orders, 95% were awarded during the Government Fiscal Years 2024 - 2026. Please see attachments for further details.
-Pre-SolicitationOpen
The Congressionally Directed Medical Research Programs (CDMRP) seeks feedback to inform the fiscal year 2027 (FY27) Alzheimer’s Research Program (AZRP) research focus areas and associated research funding opportunities. Although FY27 federal funds have not yet been appropriated, the AZRP is collecting this information solely to support strategic program planning. This inquiry does not commit the program to incorporating this feedback into FY27 or any future AZRP funding opportunities. The CDMRP wants to hear from all audiences, interested parties, and individuals from academia, industry, community and non-profit organizations, scientific and professional organizations, federal agencies, and the public. This RFI should not be construed as a solicitation or an obligation on the part of the AZRP or the Department of War (DoW). BACKGROUND: The CDMRP represents a unique partnership between the U.S. Congress, the military, and the public to fund innovative and impactful medical research in targeted program areas. The CDMRP AZRP’s vision is to mitigate the impact of Alzheimer's and related dementias associated with TBI, military, and diverse risks. The AZRP’s mission is to fund impactful, solution-oriented research to address critical needs and improve quality of life for Service Members, Veterans, their Families, and the public who are living with Alzheimer's disease and related dementias. Appropriations for the AZRP from FY11-26 totaled $228 million. As of October 2026, FY27 funds for the AZRP have not been appropriated. If appropriated, the CDMRP will utilize its two-tier review process https://cdmrp.health.mil/about/2tierRevProcess) to efficiently manage the AZRP. Additional information about the AZRP can be found here: https://cdmrp.health.mil/azrp/ RESPONSE INSTRUCTIONS: Please provide responses to this RFI by clicking on the following link: https://www.surveymonkey.com/r/FY27-AZRP-RFI
-Market Research12/04/2026
The Congressionally Directed Medical Research Programs (CDMRP) seeks feedback to inform the fiscal year 2027 (FY27) Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) research focus areas and associated research funding opportunities. Although FY27 federal funds have not yet been appropriated, TBIPRP is collecting this information solely to support strategic program planning. This inquiry does not commit the program to incorporating this feedback into FY27 or any future TBIPHRP funding opportunities. The CDMRP wants to hear from all audiences, interested parties, and individuals from academia, industry, community and non-profit organizations, scientific and professional organizations, federal agencies, and the public. This RFI should not be construed as a solicitation or an obligation on the part of the TBIPHRP or the Department of War (DoW). BACKGROUND: The CDMRP represents a unique partnership between the U.S. Congress, the military, and the public to fund innovative and impactful medical research in targeted program areas. The CDMRP TBIPHRP’s vision is to optimize the prevention, assessment, and treatment of psychological health conditions and/or traumatic brain injuries. The TBIPHRP’s mission is to fund research to understand, prevent and treat psychological health conditions and/or traumatic brain injuries that accelerates solutions to improve the health and healthcare of Service Members, their Families, Veterans, and the American public. Appropriations for the TBIPHRP from FY21-24 and FY26 totaled $740.5 million. As of October 2026, FY27 funds for the TBIPHRP have not been appropriated. If appropriated, the CDMRP will utilize its two-tier review process https://cdmrp.health.mil/about/2tierRevProcess) to efficiently manage the TBIPHRP. Additional information about the TBIPHRP can be found here: https://cdmrp.health.mil/tbiphrp/ RESPONSE INSTRUCTIONS: Please provide responses to this RFI by clicking on the following link: https://www.surveymonkey.com/r/FY27-TBIPHRP-RFI
-Market Research12/11/2026

Additional Details

Solicitation Number

HT942726RE009

Archive Date

Dec 31, 2026

Office Address

FORT DETRICK, MD, 21702